$AGO

Assured Guaranty (AGO) Q2 2026 Earnings Call Transcript

Assured Guaranty (AGO) reported Q2 2026 adjusted operating income of $55 million, or $1.23 per share, up 22% from Q2 2025. Net income was $39 million, or $0.88 per share, versus $103 million, or $2.08, a year earlier. Adjusted book value per share was $189.72 at June 30, 2026. The company also noted $19 million CLO equity mark-to-market losses and $45 million in Q2 share repurchases.

Original reporting
Published Aug 14, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 4:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Assured Guaranty (AGO) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AGONeutralMed
01

Why it matters

Key trading takeaways are record adjusted book value per share, improved adjusted operating income per share, ongoing capital returns, and explicit risk discussion around Brightline senior revenue bond liquidity pressure and CLO equity mark-to-market losses.

02

Market read

The call provides fresh quarter-specific financial metrics and risk commentary that can drive near-term repricing of capital strength versus structured finance volatility.

03

What to watch

The transcript highlights a potential soft capital facility in 2026 and acceleration of Assured Life Re bookings, which could matter more than the quarter’s headline net income decline.

Relevance 8/10Novelty 6/10Timing: post-earnings call, for positioning ahead of next-quarter expectations

Background

This is a Q2 2026 earnings conference call transcript for Assured Guaranty, covering production, capital metrics, segment results, and risk exposures.

Company-level read

Ticker impact

$AGONeutralMedium confidence
Context

Assured Guaranty reported Q2 2026 adjusted operating income of $55M, record adjusted book value per share of $189.72, and $19M CLO equity mark-to-market losses.

Expected impact

Near-term trading likely hinges on whether investors focus more on record ABV and capital returns versus CLO mark-to-market and liquidity commentary.

Evidence & confidence

The transcript provides multiple decision-relevant datapoints: per-share adjusted operating income up 22%, ABV per share at record levels, share repurchases at an average $80.68, and explicit discussion of liquidity constraints and CLO equity mark-to-market losses.

Market effects

Municipal bond insurance and structured finance investors may reprice risk around CLO equity mark-to-market volatility and liquidity management.

U.S. public finance production strength and international (Europe, Asia Pacific) growth commentary may influence regional structured finance demand expectations.

Structured finance and reinsurance capital allocation signals can affect broader credit and insurance-linked securities sentiment.

Counterpoint

Investors may overemphasize the $19M CLO equity mark-to-market loss, while the company frames alternative investment IRR as well above fixed-maturity yields.

Key entities

  • Assured Guaranty Ltd.

    Reported Q2 2026 results and discussed capital allocation, production pipeline, and exposures including Brightline bonds and CLO equity mark-to-market losses.

  • Assured Life Re

    Annuity reinsurance expansion discussed as progressing ahead of schedule with potential acceleration of bookings.

  • Brightline

    Senior revenue bond exposure discussed with liquidity constraints but no acceleration risk noted.

  • Warwick Re Limited

    Acquired in Jan. 2026, referenced in annuity reinsurance segment income.

Related articles

$CRTDLow

Creatd, Inc. (CRTD): Results of Operations and Financial Condition

Creatd, Inc. (CRTD) filed an SEC Form 8-K — Results of Operations and Financial Condition. crtd-20260814 0001357671 false 0001357671 2026-08-14 2026-08-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securitie

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$ANYMed

Sphere 3D Corp. (ANY): Results of Operations and Financial Condition

Sphere 3D Corp. (ANY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Sphere 3D Corp.: Exhibit 99.1 - Filed by newsfilecorp.com Exhibit 99.1 Sphere 3D Provides Business Update and Reports Second Quarter 2026 Financial Results Combined Company Positioned for Its Next Phase of Growth Through Power-Ready Infrastr